Why Is Spyre Therapeutics, Inc. (NASDAQ: SYRE) Stock Down Today?

Spyre Therapeutics, Inc. (NASDAQ: SYRE) Summary

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is trading up +2.14% at $102.13, reflecting a positive shift in investor sentiment today. The stock opened at $100.56 and has moved between $98.79 and $103.57 so far.

Trading volume is 762839, which is 44% below its average, and the price action suggests buying interest.

Technically, SYRE on the NASDAQ is trading above its 50-day moving average of $84.43 and above its 200-day moving average of $49.93, indicating short-term and long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns SYRE a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -7.80% in 1 month ($94.16), -50.96% in 1 year ($50.09), and -2.57% in 5 years ($99.50).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.